Beyond brand personality. A multidimensional perspective of self-congruence von Fens, Meike, Wilkie, Dean C. H., Rao Hill, Sally

Volltext

Reassessing product line breadth effectiveness: The role of heterogeneity, moderation, and cumulative effects von Charles Hugh Wilkie, Dean, Mirzaei, Abas, Pham, Ngoc, Johnson, Lester W.

Volltext

Inclusivity in Advertising: A Typology Framework for Understanding Consumer Reactions von Wilkie, Dean Charles Hugh, Burgess, Amelie Jay, Mirzaei, Abas, Dolan, Rebecca M.

Volltext

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5 von LI LIU, YICHEN CAO, CHEN, Charles, XIAOMEI ZHANG, MCNABOLA, Angela, WILKIE, Dean, WILHELM, Scott, LYNCH, Mark, CARTER, Christopher

Volltext

Towards successful diversity initiatives: the importance of building audience connectedness von Burgess, Amelie J., Wilkie, Dean C. H., Dolan, Rebecca

Volltext

BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models von Liu, Ningshu, Rowley, Bruce R, Bull, Cathy O, Schneider, Claudia, Haegebarth, Andrea, Schatz, Christoph A, Fracasso, Paul R, Wilkie, Dean P, Hentemann, Martin, Wilhelm, Scott M, Scott, William J, Mumberg, Dominik, Ziegelbauer, Karl

Volltext

Discovery and SAR of Novel 2,3-Dihydroimidazo[1,2-c]quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80-6946) von Scott, William J., Hentemann, Martin F., Rowley, R. Bruce, Bull, Cathy O., Jenkins, Susan, Bullion, Ann M., Johnson, Jeffrey, Redman, Anikó, Robbins, Arthur H., Esler, William, Fracasso, R. Paul, Garrison, Timothy, Hamilton, Mark, Michels, Martin, Wood, Jill E., Wilkie, Dean P., Xiao, Hong, Levy, Joan, Stasik, Enrico, Liu, Ningshu, Schaefer, Martina, Brands, Michael, Lefranc, Julien

Volltext

Is there a negative relationship between the order-of-brand entry and market share? von Wilkie, Dean C. H., Johnson, Lester W.

Volltext

Does the type of attribute matter? Examining whether underlying factors explain product attribute preference von Wilkie, Dean C. H., Johnson, Lester W., Chin, Wynne W.

Volltext

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis von WILHELM, Scott M, CARTER, Christopher, CAO, Yichen, SHUJATH, Jaleel, GAWLAK, Susan, EVELEIGH, Deepa, ROWLEY, Bruce, LI LIU, ADNANE, Lila, LYNCH, Mark, AUCLAIR, Daniel, TAYLOR, Ian, TANG, Liya, GEDRICH, Rich, VOZNESENSKY, Andrei, RIEDL, Bernd, POST, Leonard E, BOLLAG, Gideon, TRAIL, Pamela A, WILKIE, Dean, MCNABOLA, Angela, HONG RONG, CHEN, Charles, XIAOMEI ZHANG, VINCENT, Patrick, MCHUGH, Mark

Volltext

JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production von LaBranche, Timothy P., Jesson, Michael I., Radi, Zaher A., Storer, Chad E., Guzova, Julia A., Bonar, Sheri L., Thompson, Janice M., Happa, Fernando A., Stewart, Zachary S., Zhan, Yutian, Bollinger, Chris S., Bansal, Prashant N., Wellen, Jeremy W., Wilkie, Dean P., Bailey, Steven A., Symanowicz, Peter T., Hegen, Martin, Head, Richard D., Kishore, Nandini, Mbalaviele, Gabriel, Meyer, Debra M.

Volltext

Buyer–seller relational engagement and seller brand equity von Dwivedi, Abhishek, Miles, Morgan, Oczkowski, Eddie, Weerawardena, Jay, Johnson, Lester W, Wilkie, Dean

Volltext

The existence of double jeopardy within the order of entry effect von Wilkie, Dean C. H., Johnson, Lester W.

Volltext

Strategies used to defend pharmaceutical brands from generics von Wilkie, Dean C.H, Johnson, Lester W, White, Lesley

Volltext

Effect of antiresorptive and anabolic bone therapy on development of osteoarthritis in a posttraumatic rat model of OA von Bagi, Cedo M, Berryman, Edwin, Zakur, David E, Wilkie, Dean, Andresen, Catharine J

Volltext

Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma von ELSER, Christine, SIU, Lillian L, WILKIE, Dean, PETRENCIUC, Oana, CHEN, Eric X, WINQUIST, Eric, AGULNIK, Mark, POND, Gregory R, CHIN, Soo F, FRANCIS, Peggy, CHEIKEN, Robin, ELTING, James, MCNABOLA, Angela

Volltext

The line extension dilemma: Greater difference or similarity to existing products? von Wilkie, Dean C H, Johnson, Lester W, White, Lesley

Volltext

Woke brand activism authenticity or the lack of it von Mirzaei, Abas, Wilkie, Dean C., Siuki, Helen

Volltext

Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models von CHANG, Yong S, ADNANE, Jalila, WILKIE, Dean, CARTER, Christopher A, TAYLOR, Ian C. A, LYNCH, Mark, WILHELM, Scott, TRAIL, Pamela A, LEVY, Joan, HENDERSON, Arris, DAHAI XUE, BORTOLON, Elizabeth, ICHETOVKIN, Marina, CHEN, Charles, MCNABOLA, Angela

Volltext

Overcoming late entry: the importance of entry position, inferences and market leadership von Wilkie, Dean C.H., Johnson, Lester W., White, Lesley

Volltext